Cardiac Outcomes With Near-Complete Estrogen Deprivation

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 2, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Breast CancerTriple Negative Breast CancerCardiovascular Complications
Interventions
DRUG

Adenosine Stress Cardiac Magnetic Resonance Imaging

Adenosine stress CMR test with contrast to include cardiovascular structural and functional measures including myocardial blood flow through quantitative perfusion mapping. Participants will have 3 stress tests as a part of this research. These tests will happen when at the beginning of the study, and then every year for 2 years.

DIAGNOSTIC_TEST

Electrocardiogram

A 12-lead electrocardiogram will be done when at the start of the study and at the participant's 2 year stress test to look at the electrical signals of your heart.

DIAGNOSTIC_TEST

Computed Tomography Angiogram

Contrasted coronary CT angiography will be performed for visual and quantitative analysis of coronary artery plaque burdens.

OTHER

Laboratory Testing

10 teaspoons of blood will be withdrawn at every visit that participants receive a stress test. Participants may have up to six blood draws associated with each imaging visit.

BEHAVIORAL

Quality of Life Survey

A general health status survey with 10 questions and should take about 5-10 minutes to finish. This survey is related to research.

Trial Locations (3)

23298

RECRUITING

Virginia Commonwealth University Massey Cancer Center, Richmond

27157

RECRUITING

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem

27710

RECRUITING

Duke Cancer Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Duke University

OTHER

NCT05309655 - Cardiac Outcomes With Near-Complete Estrogen Deprivation | Biotech Hunter | Biotech Hunter